Journal list Promote Sponsor
verified SJR 0,855 · Q1 • database Scopus / SJR & Web of Science indexed
Urologic Oncology: Seminars and Original Investigations
United States · Elsevier Inc.
workspace_premium Q1 — Oncology lock_open Open Access

Urologic Oncology: Seminars and Original Investigations

Urologic Oncology: Seminars and Original Investigations is a journal indexed in SJR in Oncology and Urology with an H index of 89. It has an SJR impact factor of 0,855 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,855.

Urologic Oncology: Seminars and Original Investigations focuses its scope in these topics and keywords: cancer, bladder, radical, men, cell, metastatic, patients, cystectomy, options, inhibitorshigh, ...

ISSN: 1078-1439
Publisher: Elsevier Inc.
Category: Oncology
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,855 Q1
H-index 89
Acceptance rate pie_chart
27% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Open Access
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,855

H-index

89

Docs (year)

266

Docs 3y

949

Total refs

8362

Cites 3y

2216

Citable 3y

928

Cites/Doc 2y

2.23

Ref/Doc

31.44

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs